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COMMENTORY 
Abstract 
Acupuncture is a very ancient form of healing which predates recorded history. The philosophy is rooted in the Taoist 
tradition which goes back over 8000 years. To date this practice although used world-wide to treat addictive behaviors has 
not been generally accepted or scientifically proven. There are however many positive reports in the literature in its 
effectiveness in reducing symptoms of withdrawal from alcohol, heroin and cocaine. In addition, due to known neuro-
chemical mechanisms associated with acupuncture, especially its role in pain relief and endogenous opioid function, clinical 
benefits in reward dependence behaviors seem parsimonious. In this review article we are hypothesizing synergy between 
acupuncture/auriculotherapy and natural activation of mesolimbic dopaminergic pathways to reduce drug hunger and 
prevent relapse. Following a review of the literature involving both of these modalities the scientific and clinical community is 
encouraged to carry out translational research in large randomized double-blinded placebo controlled investigations 
coupling these two anti-craving treatment modalities. 
 
Keywords: Acupuncture; Auriculotherapy; Dopamine; Reward Deficiency Syndrome; Neuroadaptagen Amino –Acid 
Therapy (NAAT); KB220 
 
 
C
O
M
M
E
N
T
O
R
Y
 
 
 
This work is licensed under a Creative Commons Attribution 
-Noncommercial-No Derivative Works 3.0 United States License.  
OPEN ACCESS 
 
 
 
INTRODUCTION 
Is Acupuncture Effective? 
In the last few years acupuncture and now auricular 
therapy have been used increasingly to treat substance 
use disorders (Unschuld, 1985, Han et al., 2011). Studies 
of these modalities have validated their use, and more 
studies are needed and in process. There is no doubt that 
alcoholism and drug addiction are rampant in our 
society. Otto (2003) has suggested that incorporating 
acupuncture into existing programs offers a promising 
approach. Proponents say ear acupuncture alleviates 
acute opiate withdrawal, reduces craving for all 
substances, and helps retain patients in treatment. Otto 
correctly points out that over 25 years of clinical 
experience have supported this claim, but scientific 
research has been sketchy, complicated by technical 
difficulties and often poorly designed. Perhaps most 
important for the future is the growing acceptance of this 
treatment and the willingness of both Drug Courts and 
 
 
managed–care organizations to provide it via licensed 
practitioners for use with multiple addictions. 
Drug addiction is a chronic brain disorder characterized 
by withdrawal symptoms that occur during drug 
abstinence and a high tendency to relapse. Compared 
with the currently available pharmacological 
interventions, acupuncture therapy has the potential to 
help drug addicts stay away from drugs without major 
adverse side effects. According to Han et al. (2011) “it has 
taken decades of research to optimize the parameters of 
electrical acupoint stimulation for detoxification and for 
relapse prevention, as well as to establish a safe and easy 
procedure by which drug addicts can use it on 
themselves”. The, discovery in the 1970s that 
acupuncture can trigger the release of opioid substances 
from the brain relates to the neuro-chemical 
underpinnings of substance seeking behavior or 
Substance Use Disorder (SUD). This basic research on 
animals made it possible to understand one of the 
mechanisms of action of acupuncture and to establish 
the procedure for treating drug addictions.  
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While the mechanisms of acupuncture are not fully 
understood, modern research has demonstrated that 
successful acupuncture treatment results in a number of 
changes in important body proteins that could, 
themselves, act to decrease physical symptoms. These 
include indications that acupuncture mobilizes the 
opioid peptides (i.e. enkephalins, endorphins, and 
dynorphins) or increases levels of other peptides such as 
substance P and cholecystokinin (CCK) among many 
others. There are also indications that acupuncture may 
induce alterations in certain hormones including 
Cortisol and ACTH to reduce stress (Han & Shao, 1990). 
Further, electro-acupuncture has been recently been 
shown to significantly reduce internet addiction while 
increasing self-confidence and attenuating stress (Zhu et 
al., 2009). Interestingly the authors found in a 
subsequent paper that Electro-acupuncture combined 
with psychological intervention can significantly 
improve anxiety state and the mechanism is possibly 
related with the decrease of Norepinephrine (NE) in the 
body (Zhu, 2008).This has been supported by others in 
terms of treating multiple addictions (Handley, 2009). 
While acupuncture is widely utilized to treat cocaine 
addiction to date the actual scientific evidence does not 
support its singular role. Seven studies with a total of 
1,433 participants were included in a study by Gates et 
al. (2006). All were of generally low methodological 
quality. No differences between acupuncture and sham 
acupuncture were found for attrition RR 1.05 (95% CI 
0.89 to 1.23) or acupuncture and no acupuncture: RR 1.06 
(95% CI 0.90 to 1.26) eitherneither for any measure of 
cocaine or other drug abuse. The number of participants 
included in meta-analyses was low, and power was 
limited. Gates et al. suggested that there is currently no 
evidence that auricular acupuncture is effective for the 
treatment of cocaine dependence. The evidence is not of 
high quality and is inconclusive. Further randomized 
trials of auricular acupuncture may be justified. This is 
in agreement with the meta-analysis performed by Mills 
et al. (2005), D'Alberto (2004), Margolin (2003), Ter Riet et 
al. (1990) and Whitehead (1978). 
However, a study by Lipton et al. (2004) provided some 
evidence that acupuncture had positive outcome when 
utilized to prevent relapse with cocaine addicts in the 
New York City area. They found that the efficacy of 
auricular (ear) acupuncture in reducing cocaine/crack 
craving and consumption was examined via a single-
blind, placebo experiment. Specifically, one hundred and 
fifty individuals seeking treatment for cocaine/crack 
abuse were randomly assigned to receive either 
experimental or placebo acupuncture treatments. 
Treatments were provided in an outpatient setting for a 
one-month period. Placebo treatments involved 
acupuncture at ear locations not used for drug 
treatment. Subjects provided urine specimens for drug 
content analysis after each acupuncture session. 
Urinalysis results over the one-month study period 
favored the experimental group. Experimental subjects 
in treatment over 2 weeks had significantly lower 
cocaine metabolite levels relative to placebo subjects in 
treatment for a comparable period. Treatment retention 
with both groups was similar. Relative to pretreatment 
usage, a significant decrease in cocaine consumption was 
reported by both groups.  
Courbasson et al. (2007) found that compared to women 
in the control group women receiving acupuncture 
reported having reduced physiological cravings for 
substances, felt significantly less depressed, less anxious, 
and were better able to reflect on and resolve difficulties. 
. The authors concluded that auricular acupuncture, as 
an adjunct therapy to a comprehensive psycho-
educational treatment program for women with 
addictions, shows promise as a more viable and 
effective, non-drug treatment alternative to anxiolytics.  
Since scientific research has shown that addiction, 
withdrawal, and recovery are all related to brain 
chemicals such as the opioid peptides and to stress 
regulating hormones in the body, it is reasonable, then, 
that use of procedures that affect these systems be 
explored.  Some may be reluctant to trust the 
effectiveness and safety of acupuncture and 
auriculotherapy. However, the U.S. Food & Drug 
Administration (FDA) has recognized electrical devices 
used in auriculotherapy and the acupuncture needle as 
medical devices. Research support for the effectiveness 
of the procedures is abundant and will be discussed 
later. While there are some who claim that there are not 
enough sound clinical studies to support efficacy of 
acupuncture, ear acupuncture or auriculotherapy, others 
would support its use. It is our contention that, in light 
of the positive studies, it would be unwise to dismiss its 
use as being worthless and that many more controlled 
studies are warranted (Micozzi, 1996). 
Acupuncture 
Acupuncture dates back thousands of years. Specifically, 
acupuncture is 6000 years old and ear acupuncture is 
2,500 years old. In essence, traditional Chinese healers 
seek to restore a dynamic balance between two 
complementary forces that pervade the human body and 
travel through meridians as CHI (life energy). 
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Acupuncture corrects the excess or the deficiency of CHI 
along meridians. Acupuncture involves stimulation of 
certain points on the skin, mostly with ultra fine needles 
that are manipulated manually or electrically (Kaptchuk, 
1984, Maciocia, 1989).  
Today, acupuncture is practiced internationally; its 
practitioners include professional acupuncturists and a 
variety of other health care providers including medical 
doctors. Upward of 2,000 acupuncture points are now 
recognized by licensed acupuncturists. By 1982 there 
were enough acupuncture schools to warrant the 
development of the National Council of Acupuncture 
Schools and Colleges, which evolved into the 
Accreditation Commission for Acupuncture and 
Oriental Medicine or ACAOM. Today over 30 programs 
are within ACOM’s purview.  
Most states permit licensed physicians to perform 
acupuncture as part of their medical practice, but this 
may vary from state to state. Most states provide for the 
practice of acupuncture by chiropractors on the basis of 
an additional 100-200 hours of training. Many states 
have adopted legislation to permit the practice of 
acupuncture by individuals who are not medical doctors 
or chiropractors such as doctors of naturopathy, 
podiatrists, physical therapists, physician’s assistants, 
nurses and counselors, but training requirements vary.  
Ear Acupuncture in the treatment of Substance Use 
Disorder (SUD) 
As stated earlier, acupuncture has been around for 
thousands of years. In more recent times Hsiang Lai 
Wen of Hong Kong successfully applied electrical 
stimulation to one point in the ear to relieve opiate 
withdrawal symptoms. Inspired by this work, Michael 
Smith, an American physician, first used the Wen 
protocol as part of a methadone program at Lincoln 
hospital in Bronx, New York. Over several years, Smith 
and co-workers refined the detox protocol into five ear 
points that are needled without electrical stimulation. To 
promote his protocol, Smith founded the National 
Acupuncture Detoxification Association (NADA), and 
for the past 35 years he has championed the use of 
acupuncture detox in a wide variety of clinical settings 
including county jails, maximum-security prisons, 
outpatient drug treatment programs, homeless shelters, 
and mental health facilities. Smith has championed the 
effective use of acupuncture to treat pain (Smith and 
Tong, 2005).  
At about the same time, Haight-Ashbury Free Clinic 
(HAFC) in San Francisco began to utilize acupuncture 
for the treatment of addiction. In fact, I published a 
paper with others at the HAFC on the favorable outcome 
of utilizing ear acupuncture in alcoholic withdrawal 
(Blum et. al., 1978). 
Auriculotherapy  
The original work of Paul Nosier, M.D. of Lyon, France 
in 1956 provided the world with what is now called 
auriculotherapy. A common misconception is that 
auriculotherapy is ear acupuncture. While ear 
acupuncture depends on the use of needles inserted 
among a fixed set of alleged acupuncture points, 
auriculotherapy does not involve fixed points and does 
not use needles. Auriculotherapy points are created by 
innervations of four cranial nerves and three cervical 
ganglia. These are not acupuncture points. The 
professional uses a hand-held STIM PLUS PRO (an FDA 
class 11 medical device) shaped like a pen to (1) locate 
the auriculotherapy point, (2) diagnose the located 
auriculotherapy point, and (3) treat the auriculotherapy 
point if measured to be abnormal.     
Auriculotherapy is defined as the location and treatment 
of neurological points in the ear by micro current 
stimulation. Each point is treated by the hand-held pen-
shaped device (described above) for 30 seconds. The 
procedure is painless. Both ears are treated five days a 
week for 15-30 days for 10 minutes. In contrast ear 
acupuncture, needles must be left in place for 45 minutes 
to 1½ hours. 
Auriculotherapy in the Treatment of Substance Use 
Disorder (SUD) 
In 1991, in conjunction with others (Blum and Holder, 
2000) my laboratory conducted the first government-
funded study to formulate and further develop 
auriculotherapy as a treatment modality for SUD. Today, 
auriculotherapy is in wide use as a successful modality 
for both addiction treatment and detoxification. 
Hundreds of drug courts, residential and outpatient 
treatment centers, private practitioners, and addiction 
counselors have combined auriculotherapy with group 
therapy, one-on-one counseling, and psychotherapy. In 
1993, the National Consortium of TASC Programs 
(NCTP) listed auriculotherapy as number one among 
185 treatments effective as alternatives to street crime. 
As mentioned earlier, the National Acupuncture 
Detoxification Association (NADA) has selected five ear 
acupuncture points for the treatment of SUD and the 
Blum et al. (2011) IIOAB Letters, 1: 8-20 
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relief of opiate withdrawal. Today a number of clinicians 
are using a newer protocol. Six foundation points are 
stimulated transcutaneously, using frequency specific 
micro-currents. While research suggests that this 
modality can reduce a patient’s physiological symptoms 
and physiological cravings, motivation to abstain is still 
required by the patient. 
In certain states counselors can perform auriculotherapy 
for detoxification and treatment of multiple drug 
addictions without an acupuncture license since no 
needles are required.  There are some other advantages: 
 No risk of Hepatitis, HIV or other infections 
because no needles are used. 
 Less than 10-minute treatment time compared to 
one-hour with ear acupuncture. 
 Useful for both detoxification as well as treatment 
of multiple drug addictions, not just for opiate 
dependence. 
 Micro current devices both locate and treat points. 
 It can address the patient’s drug of choice by 
adding or subtracting certain points accordingly.  
Research Support for Acupuncture and 
Auriculotherapy  
Since the late 1970’s and the 1980’s numerous studies 
have been performed in order to evaluate acupuncture 
and recently auriculotherapy in the treatment of 
addictive behaviors. A recent MEDLINE search found 
over 16,647 studies dealing with the use of acupuncture 
(in all forms) for SUD including alcoholism, heroin 
addiction, and stimulant abuse, binge eating and 
smoking behavior. The majority of data come from the 
most obvious application of acupuncture: the attempt to 
decrease the pain and other discomforts associated with 
opiate addiction. A number of positive studies by Wen 
in 1977 showed intense relief of withdrawal symptoms 
within 15 minutes of the beginning of the procedures. A 
subsequent one-year follow-up of the sample by 
Schuckit and associates revealed that 51% had been free 
of drugs during the interval. In 1985, Kroening and 
Oleson found that the combination of precipitous opiate 
withdrawal along with auriculotherapy was successful, 
with 86% of the patients withdrawing within five to 
seven days with a minimum of side effects. Currently 
the literature reveals a number of positive studies using 
acupuncture, ear acupuncture, or auriculotherapy 
including: smoking (He et al., 1997), alcoholism (Brewer, 
1995); cocaine addiction (Otto et al., 1998), opiate 
addiction (Washburn et al., 1993) and SUD (Gurevish et 
al., 1996).   
In comparison, a number of negative studies involving 
the efficacy of both acupuncture and ear acupuncture 
(according to the type of addiction) include smoking 
(Martin & Waite, 1981), alcoholism (Worner et al., 1992), 
cocaine addiction (Bulloock et al., 1999), and opiate 
addiction (Man & Chaung, 1980). In 1990, a meta 
analysis revealed that a number of studies were 
negative. The authors reported 22 controlled clinical 
negative studies in three fields of addiction: cigarette 
smoking (15), heroin (five), and alcohol (two). 
Here are few examples of scientifically sound studies 
that support the use of acupuncture (in all forms) and 
auriculotherapy: 
1. In a placebo–controlled study, 80 severe recidivist 
alcoholics received acupuncture either at points 
specific for the treatment of substance abuse 
(treatment group) or at nonspecific points (control 
group). Twenty–one of forty patients in the 
treatment group completed the program compared 
with one of forty controls. Significant treatment 
effects persisted at the end of the six–month follow-
up: by comparison with treatment patients more 
control patients expressed a moderate to strong need 
for alcohol and had more than twice the number of 
both drinking episodes and admissions to a 
detoxification center (Bullock et al., 1989). 
2. In 66 residential patients using auriculotherapy and 
a six-point system; patients in the placebo group 
performed worst, with a retention rate below 65.5%. 
However, the auriculotherapy group had a retention 
rate of 96% and in comparison to the standard 
residential group’s retention of 72%, a patient was 
ten times likely to complete a 30-day residential 
treatment program than one without 
auriculotherapy (Holder et al., 2001). 
3. A recent Yale study reported on a randomized 
controlled trial of ear acupuncture in cocaine–
dependent subjects. Of the patients studied, 53.8% of 
those receiving the acupuncture treatment tested 
free of cocaine during the last week of the study, 
compared with 23.5% and 9.1% in the two control 
groups. Those who completed the acupuncture 
treatment also had longer periods of sustained 
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abstinence than participants in either control group 
(Savants et. al., 2000). 
4. Research published in the Journal of Substance 
Abuse Treatment from the Consortium Treatment 
Center in Klamath Falls, Oregon (Russell et al., 2000), 
reveals that acupuncture detoxification had the 
following measurable outcomes among court 
mandated, chronic offenders: (1) increased patient 
retention, (2) reduced number of arrests, (3) more 
drug-free urinalysis, and (4) decrease in the number 
of days needed for successful patient progress. The 
authors used a five–point approved and established 
protocol as defined by the National Acupuncture 
Detoxification Association (NADA). 
Drug Court and Acupuncture  
The Drug Court is one of the most famous programs to 
incorporate the use of acupuncture detox treatment in 
the United States. Janet Reno, the former Attorney 
General, was one of the founders of the original Drug 
Court in Dade County, Florida in 1989. Over the past 15 
years, Drug Court programs have switched the criminal 
justice approach to drug abuse from an approach based 
in punishment to one rooted in rehabilitation (US Senate 
Subcommittee, 1993).  
In general, if drug offenders, including D.U.I. offenders, 
decide to participate in a typical one–year Drug Court 
program, their arrest will be erased from their record 
and they will be released from probation. For example 
Sacramento based Drug Court employs a licensed 
acupuncturist .In this program, along with drug testing 
and counseling, clients receive auricular acupuncture 
five days a week. The following are brief anecdotal 
remarks from a number of patients receiving 
acupuncture in drug courts: 
Patient Comments include a number of very positive 
responses. In this regard here are a few to consider: “A 
change in attitude.” “Moods are less erratic.” “Feeling 
good from within.” “Full of energy.” “Headache is 
gone.” “Now actually sleeping.” “This was the quickest I 
kicked heroin.” “It reduces my craving for booze, and it 
brought back my natural energy.” “ I feel less stress.” “ 
I’m calmer.”  “Before acupuncture, even though I was 
clean I never once stopped craving drugs. Since 
acupuncture, I’ve stopped the craving.” 
Counselors of drug court had this to say: “Patients are 
coming in more balanced emotionally, mentally and 
physically.” “I have seen tremendous results with 
acupuncture for my patients.” 
In reviewing the past scientific history of the potential 
efficacy of Acupuncture in all forms no definitive 
conclusion can be reached.  However, because of the 
common neuro-chemical effects of acupuncture and 
mesolimbic reward impairment linked to all addictive 
behaviors coined Reward Deficiency Syndrome(RDS) 
(Blum et al., 1996) it would be parsimonious to develop a 
research protocol that combines natural dopaminergic 
activation with acupuncture induced enhance  opioid 
activity for RDS.   
Reward Circuitry Opioid- Dopaminergic Connectivity 
as a Therapeutic Target for Reward Deficiency 
Syndrome (RDS) 
Since the discovery of the double helix, explorations of 
brain function in terms of both physiology and 
behavioral traits have resulted in a plethora of studies 
linking these activities to neurotransmitter functions 
having a genetic basis. The mechanisms underlining 
gene expression and the potential impairments due to 
polygenic inheritance -- and as such, predisposition to 
addiction and self-destructive behaviors have been 
studied. Our studies have shown that the prevalence of 
the dopamine D2 receptor gene (DRD2) A1 allele in 
Cocaine dependent (CD) subjects (n = 53) was 50.9%. It 
was significantly higher than either the 16.0% prevalence 
(P < 10(-4)) in non-substance abusing controls (n = 100) 
or the 30.9% prevalence (P < 10(-2)) in population 
controls (n = 265) wherein substance abusers were not 
excluded. Logistic regression analysis of CD subjects 
identified potent routes of cocaine use and the 
interaction of early deviant behaviors and parental 
alcoholism as significant risk factors associated with the 
DRD2 A1 allele.  The cumulative number of these risk 
factors in CD subjects was positively and significantly (P 
< 10-3) related to DRD2 A1 allelic prevalence. The data 
showing a strong association of the minor alleles (A1 
and B1) of the DRD2 with CD indicates that a gene, 
located on the q22-q23 region of chromosome 11, confers 
susceptibility to this drug disorder (Noble et al., 1993). 
Over half a century of dedicated and rigorous scientific 
research on the mesolimbic system, has provided insight 
into the addictive brain and the neurogenetic 
mechanisms involved in man’s quest for happiness 
(Blum et al., 2009). In brief, the site of the brain where 
one experiences feelings of wellbeing is the mesolimbic 
system. This part of the brain has been termed the 
Blum et al. (2011) IIOAB Letters, 1: 8-20 
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“reward center”. Chemical messages including 
serotonin, enkephalins, GABA, and dopamine (DA) 
work in concert to provide a net release of DA at the 
nucleus accumbens (NAc), a region in the mesolimbic 
system. It is well known that genes control the synthesis, 
vesicular storage, metabolism, receptor formation, and 
neurotransmitter catabolism. The polymorphic versions 
of these genes have certain variations that could lead to 
an impairment of the neurochemical events involved in 
the neuronal release of DA.  The cascade of these 
neuronal events has been termed “Brain Reward 
Cascade”.  See Figure 1. A breakdown of this cascade 
ultimately leads to a dysregulation and dysfunction of 
DA. Since DA has been established as the “pleasure 
molecule” and the ”anti-stress molecule,” any reduction 
in its function could lead to reward deficiency and 
resultant aberrant substance seeking behavior and a lack 
of wellness (Blum et al., 2000). 
It is well known that humans are biologically 
predisposed to drink, eat, reproduce, and desire 
pleasurable experiences (Tindell et al., 2006, Peciña et al., 
2006). Impairment in the mechanisms involved in these 
natural processes lead to multiple impulsive, 
compulsive, and addictive behaviors governed by 
genetic polymorphisms. While there are a plethora of 
genetic variations at the level of mesolimbic activity, 
polymorphisms of the serotonergic-2A receptor (5-
HTT2a), serotonergic transporter (5HTTLPR), dopamine 
D2 receptor (DRD2), dopamine D4 receptor (DRD4), 
dopamine transporter (DAT1), and Catechol-o-methyl–
transferase (COMT), and monoamine–oxidase (MOA) 
genes, as well as other genes, predispose individuals to 
excessive cravings and resultant aberrant behaviors. 
An umbrella term to describe the common genetic 
antecedents of multiple impulsive, compulsive, and 
addictive behaviors is RDS. Individuals possessing a 
paucity of serotonergic and/or dopaminergic receptors 
and an increased rate of synaptic DA catabolism, due to 
high catabolic genotype of the COMT gene, or high 
MOA activity are predisposed to self-medicating with 
any substance or behavior that will activate DA release 
including alcohol, opiates, psychostimulants, nicotine, 
glucose, gambling, sex, and even excessive internet 
gaming, among others. Use of most drugs of abuse, 
including alcohol, is associated with release of dopamine 
in the mesocorticolimbic system or “reward pathway” of 
the brain (Di Chiara, 1995). Activation of this 
dopaminergic system induces feelings of reward and 
pleasure. However, reduced activity of the dopamine 
system (hypodopaminergic functioning) can trigger 
drug-seeking behavior. Variant alleles can induce 
hypodopaminergic functioning through reduced 
dopamine receptor density, blunted response to 
dopamine, or enhanced dopamine catabolism in the 
reward pathway.  Cessation of chronic drug use induces 
a hypodopaminergic state that prompts drug-seeking 
behavior in an attempt to address the withdrawal–
induced state (Berridge, 2009). 
Acute utilization of these substances can induce a feeling 
of wellbeing. But, unfortunately sustained and 
prolonged abuse leads to a toxic pseudo feeling of well 
being resulting in tolerance and disease or discomfort. 
Thus, normal or high DA receptors results in low 
craving whereas low DA receptors due to carrying the 
DRD2 A1 allelic genotype results in excessive cravings 
and consequential drug seeking behavior. In terms of 
preventing substance abuse, or excessive glucose 
craving, one goal is to induce a proliferation of DA D2 
receptors in genetically prone individuals. Experiments 
in vitro have shown that constant stimulation of the DA 
receptor system via a known D2 agonist in low doses 
results in significant proliferation of D2 receptors in spite 
of genetic antecedents. In essence D2 receptor 
stimulation signals negative feedback mechanisms in the 
mesolimbic system to induce mRNA expression causing 
proliferation of D2 receptors (Boundry et al., 1996). This 
molecular finding serves as the basis to naturally induce 
DA release to also cause the same induction of D2-
directed mRNA and thus proliferation of D2 receptors in 
the human. This proliferation of D2 receptors in turn, 
will induce the attenuation of craving behavior. In fact 
this has been proven with work showing DNA–directed 
over-expression (a form of gene therapy) of the DRD2 
receptors and significant reduction in both alcohol and 
cocaine craving-induced behavior in animals (Filtz et al., 
1994). These observations are the basis for the 
development of a functional hypothesis of drug–seeking 
and drug use. The hypothesis is that the presence of a 
hypodopaminergic state, regardless of the source, is a 
primary cause of drug–seeking behavior. Thus, genetic 
polymorphisms that induce hypodopaminergic 
functioning may be the causal mechanism of a genetic 
predisposition to chronic drug use and relapse. Finally, 
utilizing the long term dopaminergic activation 
approach will ultimately lead to a common safe and 
effective modality to treat RDS behaviors including 
Substance Use Disorders (SUD), Attention Deficit 
Hyperactivity Disorder (ADHD), and obesity among 
other reward deficient aberrant behaviors (Rothman & 
Glowa, 1995, Peng et al., 2010). 
Support for the impulsive nature of individuals 
possessing dopaminergic gene variants is derived from a 
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number of important studies illustrating the genetic risk 
for drug-seeking behaviors based on association and 
linkage studies implicating these alleles as risk 
antecedents having impact in the mesocorticolimbic 
system (see Figure 1).. 
Figure 1. Schematic of Brain Reward Cascade normal and abnormal representation. (A) 
Represents the normal physiologic state of the neurotransmitter interaction at the mesolimbic 
region of the brain.  Briefly, serotonin in the hypothalamus stimulates neuronal projections of 
methionine enkephalin in the hypothalamus that, in turn, inhibits the release of GABA in the 
substania nigra, thereby allowing for the normal amount of Dopamine to be released at the 
Nucleus Accumbens (NAc; reward site of the brain). (B) Represents hypodopaminergic 
function of the mesolimbic region of the brain.  The hypodopaminergic state is due to gene 
polymorphisms as well as environmental elements, including both stress and neurotoxicity from 
aberrant abuse of psychoactive drugs (i.e. alcohol, heroin, cocaine etc). Genetic variables 
include serotonergic genes (serotonergic receptors [5HT2a]; serotonin transporter 5HTlPR); 
endorphinergic genes (the mu OPRM1 gene; proenkephalin (PENK); PENK polymorphic 3' 
UTR dinucleotide (CA) repeats}; GABergic genes (GABRB3); and dopaminergic genes 
(including ANKKI Taq A; DRD2 C957T, DRD4 7R, COMT Val/met substitution, MAO-A uVNTR, 
and SLC6A3 9 or 10R).  Any of these genetic and or environmental impairments could result in 
reduced (Blum et al, 2010).
 
In doing association studies that require a representative 
control sample for a single RDS psychiatric diagnosis or 
for potential subsets of RDS, one limitation relates to 
controls poorly screened for multiple RDS behaviors and 
other related psychiatric disorders (Neiswanger et al., 
1995). Missing behaviors that are part of the RDS subset 
may be the reason for spurious results when genotyping 
for single subsets of RDS behaviors. For example, in our 
unpublished study, an individual may not drink alcohol 
or use drugs but may have other RDS behaviors such as 
overeating or intensive video-gaming.  In support of 
this, a very strong association of the dopamine D2 
receptor A1 allele (100%) was found in one family 
(Family A) studied over five generations. In addition, 
every individual in another family, Family B, also had at 
least one dopaminergic high risk allele (100%) (48% 
carried the DRD2 A1 allele). Moreover, in Family B only 
three adult individuals exhibited no addictive behavior. 
When compared to results in which 55 RDS subjects 
carried the DRD2 A1 allele at a frequency of 78.2% and 
the results of a study in which 597 severe alcoholics 
carried the A1 allele at a frequency of 49.3%, there was a 
significant difference between these two groups 
(X2=16.9, p<0.001).  This demonstrated that the A1 
allele’s prevalence increases with multiple RDS 
behaviors.  The results from these experiments show that 
multifaceted non-specific RDS behaviors should be 
considered as the true “reward” phenotype 
(endophenotype) instead of a single subset RDS 
behavior such as alcoholism.  
With this stated it is interesting that the Canadian 
scientists, Bruce Pomeranz and Robert Cheng (1980), 
found that the amino acid D-phenylalanine has been 
shown to potentiate the analgesic effects of acupuncture 
in rodents. Specifically, the D-amino acids, D-
phenylalanine and D-leucine, produce naloxone 
reversible analgesia. Electro-acupuncture also produces 
analgesia which is blocked by naloxone. Combining the 
two treatments produces an additive effect with a larger 
analgesia than that produced by either treatment given 
alone; this combined effect is also blocked by naloxone. 
Moreover only 62% of the mice show electro-
acupuncture analgesia and 53% show D-amino acid 
analgesia; 80% of the animals show marked analgesia 
with both electro-acupuncture plus D-phenylalanine 
treatment. Perhaps the combination of electro-
acupuncture with D-phenylalanine will provide a potent 
method for the treatment of clinical pain. 
With this in mind, our laboratory engaged in a scientific 
study to assess the result of combining neuroadaptagen -
amino acid therapy (NAAT-KB220) and acupuncture to 
treat clients in a Drug Court setting. It is noteworthy that 
since the nutritional supplement component of 
Sacramento’s Drug Court began in July 1998, the 
percentage of program graduates has risen by 39 percent 
(personal communication with Carolyn Reuben of 
Sacramento’s drug Court Program). In one program, the 
combination of counseling, acupuncture, and amino acid 
therapy (both oral & intravenous) has produced 
significant positive results in preventing relapse (Blum et 
al., 2007). 
In Las Vegas, we studied a total of seventy six patients 
who attended a drug and alcohol treatment program 
The study  combined auriculotherapy and nutraceutical 
Blum et al. (2011) IIOAB Letters, 1: 8-20 
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brain rebalancing The precursor amines and nutrients 
included: Dl-phenylalanine, L-glutamine, L-tyrosine, 5-
hydroxytryptophane, Rhodiola rosea and chromium 
picolinate.(Blum et al. 2000). The clients were derived 
from four referral sources: Clark County District 
Attorney Office, Clark County Drug Court Program, US 
Federal Court System, and Self Referral. The patients 
were multiple DUI offenders and serious drug and 
alcohol offenders (see table 1).  
Specifically, the Chen et al. (2007) study evaluated the effects of 
a putative activator of brain reward circuitry on outcomes in a 
one year (1y) prospective comprehensive outpatient clinical 
program called the Gene Narcotic Attenuation Program 
(GNAP), administered for the treatment of SUD. Seventy-six 
patients (45 males and 31 females; mean age, 33 y [standard 
deviation, 7.0]) who had been given a diagnosis of serious 
substance use disorder were recruited. After exclusion of 15 
patients who dropped out before the end of the study, self-
reported craving decreased from program entrance to 12 wk 
(visual analog scale whereby 0 represents no craving and 5, the 
strongest craving) for 61 compliant patients (mean decrease, 
2.85, 95% confidence interval [CI], 2.65, 3.05); this improvement 
was significant (P<.001). Building up to relapse scores (each of 
5 individual items and summary value) showed similar 
improvement after 1 y of treatment; the mean decrease in 
scores was significant for stress (t=3.3; P=.002), depression 
(t=4.0; P<.001), anger (t=4.4; P<.001), anxiety (t=4.5, P<.001), 
drug craving (t=5.4, P<.001), and summary building up to 
relapse (t=4.1; P<.001). Also, recovery score measures of energy 
level (t=8.4; P<.001) and ability to refrain from drug-seeking 
behavior (t=7.4; P<.001) showed significant mean increases 
from entry to 1 y. During the study, the alcoholic dropout rate 
was only 7% (4 of 57), which was significantly (Fisher's exact 
test, P<.001) lower than the 73% (11 of 15) dropout rate 
reported for psychostimulant users. Although these results are 
significant, any interpretation must await the performance of 
rigorous double-blind studies. 
 If we calculate the percent relapse of the entire program which 
included a total of 76 patients with a total of 15 patients that 
dropped out, it is a remarkable 19.9 % relapse rate. When we 
compare relapse rates obtained from the literature: 56% for 
alcoholics and 90% for cocaine or stimulant dependent 
subjects, our result is quite significant. Our finding which 
translates to 79.1% recovery is considered by the Court system 
significant. The main observation is that unlike all other 
treatments tried by the court system these patients after a 
3month period showed great improvement in all physiological, 
psychological and even spiritual levels (Chen et al., 2007).   
Table 1.  Genetic Narcotic Attenuation Program Data 
Clark County District 
Attorney Referral 
Clark County US Federal 
Courts 
Self Referral 
15 patients 42 patients 10 patients 8 patients 
Assessed after 11 
months 
Assessed after 
8 months 
Assessed after 
5 months 
Assessed after11 
months 
2 patients dropped out 11 patients 
dropped out 
2 patients 
dropped out 
No drop out 
13.33% relapse  23.2% relapse  20% relapse No relapse 
 
Figure 2a. Comparison AMA Rate Control vs KB200Z (Study 1. Blum et al., Curr Therp Res. 
43: 1204-1214, 1988; Study 2. Blum et al. ,Alcohol 5: 481-493, 1989).
 
 
There are two important clinical outcomes using NAAT 
{KB220 variant-SynaptaGenX (SGX)]: (1) reduction in Against 
Medical Advice (AMA) rates (Figure 2a) (2) relapse prevention 
(Figure 2b). 
From the results of these two independent studies we 
cautiously suggest that KB220 variant significantly prevents 
AMA rate in a population of in-patient cocaine addicts.  
Compared to controls (no KB220 variant) whereby the AMA 
rate in the first five days of in-patient treatment was 37.5% of 
the population leaving the program, the KB220 group of 
subjects had only a 4.2 percentage  AMA rat which was 
significant at the (p <0.014) (Blum et  al., 1988). In a second 
double –blinded randomized placebo controlled study in 
alcoholic in-patients similar reduction of AMA was observed. 
In the placebo group the AMA rate in the first five days was 
24%  compared to only 3.3 percent in the KB220 group ( P 
<0.05) (Blum et al., 1989).  
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Figure 2b. Without vs with KB200Z Variant (Study 1. Brown et al., Journal of Psychoactive 
Drugs 22:173-187 (1990); Study 2. Chen et al., Adv Therp. 24:402-414 (2007) 
From the results of these two independent studies we 
cautiously suggest that KB220 variant significantly reduces 
relapse rates in poly drug abusers attending out-patient clinics. 
In one study in cocaine and alcohol addicts attending a DUI 
offenders program in San Francisco evaluated over a 10 month 
period, the relapse rate for cocaine addicts was 33% percent 
compared to a Centrum® vitamin control group relapsing at 
87% (P<0.001) and for alcoholics it was only 13% compared to 
53% for the control group (p<0.001) (Brown et al., 1990). 
Similarly, the relapse rate for alcoholics attending an out-
patient program in Las Vegas , Nevada over a 10 month period  
was only 7% for the KB220 Variant group compared to 50% of  
literature controls (no KB220 variant) and for heroin addicts 
zero percent relapsed compared to 70% of literature controls 
(P<0.001). 
 
Most recently our laboratory (Blum et al.,2010) obtained 
positive outcomes demonstrated by quantitative  
electroencephalographic (qEEG) imaging in a randomized, 
triple-blind, placebo-controlled, crossover study involving oral 
KB220Z™ showed an increase of alpha waves and low beta 
wave activity in the parietal brain region (Figure 3).Using t 
statistics, significant differences observed between placebo and 
KB220Z™ consistently occurred in the frontal regions after 
week 1 and then again after week 2 of analyses (P = 0.03). This 
is the first report to demonstrate involvement of the prefrontal 
cortex in the qEEG response to a natural putative D2 agonist 
(KB220Z™), especially evident in dopamine D2 A1 allele 
subjects. Independently, we have further supported this 
finding with an additional study of 3 serious polydrug abusers 
undergoing protracted abstinence who carried the DRD2 A1 
allele. Significant qEEG differences were found between those 
who received 1 dose of placebo compared with those who were 
administered KB220Z™. Moreover, KB220Z™ induced 
positive regulation of the dysregulated electrical activity of the 
brain in these addicts. The results are indicative of a phase 
change from low amplitude or low power in the brain to a 
more regulated state by increasing an average of 6.169 mV(2) 
across the prefrontal cortical region. In the first experiment we 
found that while 50% of the subjects carried the DRD2 A1 
allele, 100% carried ≥ 1 risk allele. Specifically, based on the 
proposed addiction risk score for these 14 subjects, 72% had 
moderate-to-severe addiction risk. Similar findings were 
obtained by repeating the experiment in 3 additional currently 
abstinent polydrug abusers carrying the DRD2 A1 allele. 
 
Figure 3. qEEG Study: KB220Z compared to placebo in psychostimulant addicts 
We concluded that this seminal work will provide 
important information that may ultimately lead to 
significant improvement in the recovery of individuals 
with psychostimulant and polydrug abuse problems, 
specifically those with genetically induced dopamine 
deficiency. Based on this small sample size, we are 
proposing that with necessary large populations 
supporting these initial results it is possible incorporate  
a safe, nonaddicting, natural dopaminergic receptor 
agonist that potentially up-regulates instead of down-
regulates dopaminergic receptors, preferably the D2 
subtype (Blum et al., 2008).  
The clinical benefits of NAAT [KB220 variants] have been 
reviewed by Chen et al., (2011) showing significant anti-RDS 
behaviors. Interestingly the effects are in-part attributable to 
meso-limbic dopaminergic activation as well as significant 
regulation of Prefrontal Frontal Cortex - Cingulate Gyrus 
dysregulation (site for addiction relapse). Moreover, 
unpublished data derived from preliminary pilot fMRI study 
in China revealed BOLD response at the Caudate –NAc brain  
region in heroin addicts compared  to placebo, indicating 
dopaminergic activation. 
Blum et al. (2011) IIOAB Letters, 1: 8-20 
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CONCLUSION 
Acupuncture is especially attractive because it does not 
involve long-term administration of medications. There 
is a potential for future studies using either acupuncture 
or auricular therapy, especially in the field of stimulant 
withdrawal. Finally, all published reports to date 
suggest that acupuncture (in all forms) is likely to be of 
optimal use when combined with additional treatments 
such as amino acid therapy (both oral and intravenous), 
psychotherapy, counseling, education, outreach to the 
family, and appropriate self-help groups. 
There are 1200 substance abuse treatment programs in 
the US and abroad using acupuncture, and the number 
of drug treatment programs incorporating acupuncture 
is growing each year. Recovery from addiction is 
difficult and subject to relapse. People in recovery need 
more tools like acupuncture and auriculotherapy 
coupled with NAAT to improve the quality of recovery 
as well as to reduce the risk of relapse. This notion is 
based on the mutual synergistic action of both 
acupuncture and NAAT. Acupuncture increases 
enkephalinergic activation and enhances neuronal 
release of the opioid peptide. In fact known 
enhancement of opiate function through acupuncture 
leads to a preferential release of dopamine due to GABA 
inhibition via mu opiate receptor stimulation.  Thus the 
combination of acupuncture with NAAT which 
indirectly activates caudate –accumbens dopaminergic 
pathways will result in neurochemical synergy between 
these two non –drug modalities.  We are encouraging 
our peers to further investigate in randomized –double-
blind placebo controlled studies this potentially novel 
anti-craving modality to treat RDS. 
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